首页> 外国专利> Use of ICK and KLC3 for the diagnosis of ciliary injury disease

Use of ICK and KLC3 for the diagnosis of ciliary injury disease

机译:使用ICK和KLC3进行睫状损伤疾病的诊断

摘要

The present invention relates to the use of ICK and KLC3 for the diagnosis of ciliary damage disease, and to a formulation for preventing or treating ciliary damage disease comprising a KLC3 inhibitor, ICK defect through knockout in the kidney of an animal model By confirming that cilia are damaged, cyst is formed, and KLC3 protein is increased, demonstrating that ICK defect and KLC3 increase are indicators of ciliary damage, we propose ICK and KLC3 as biomarkers for the diagnosis of ciliary damage disease. In addition, the present invention confirms that cysts formed by ICK defects in renal epithelial cells are improved by suppressing KLC3 protein, thereby providing an inhibitor of KLC3 protein activity or KLC3 mRNA expression as a prophylactic or therapeutic agent for ciliary damage disease do.
机译:本发明涉及ICL和KLC3用于诊断睫状损伤疾病的使用,以及用于预防或治疗包含KLC3抑制剂的睫状损伤疾病的制剂,通过证实纤毛通过敲除通过敲除通过敲除的蛋白质 受损,形成囊肿,随着KLC3蛋白增加,表明ICL缺陷和KLC3增加是睫状损伤的指标,我们将ICL和KLC3作为生物标志物诊断睫状损伤疾病。 另外,本发明证实通过抑制KLC3蛋白,通过肾上皮细胞中的ICK缺陷形成的囊肿,从而提供KLC3蛋白活性或KLC3 mRNA表达作为睫状损伤疾病的预防或治疗剂的抑制剂。

著录项

  • 公开/公告号KR102345006B1

    专利类型

  • 公开/公告日2021-12-29

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR1020200033828

  • 发明设计人 박종훈;나규영;고혁완;고제영;

    申请日2020-03-19

  • 分类号G01N33/68;A61K31/7088;A61K31/713;A61K48;C12Q1/6883;

  • 国家 KR

  • 入库时间 2022-08-24 23:05:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号